WCG FDAnews Announces: Gene & Cell Therapy Regulation Webinar on December 14, 2022
For drug makers involved in developing gene and cell therapy products, the FDA and other regulators have made it clear: comparability studies are essential to product approval. It is critical that drug makers understand these new requirements in order to avoid minor process changes that could result in quality, efficacy or compliance challenges.
FALLS CHURCH, Va., Dec. 1, 2022 /PRNewswire-PRWeb/ -- This webinar will enable attendees to understand and comply with the FDA's cell and gene therapy requirements and avoid common errors that can result in quality, efficacy, or compliance challenges. It is critical for drug makers maintain their products' critical quality attributes (CQAs) and bring them to market.
Scott R. Burger, MD, the principal of Advanced Cell & Gene Therapy, and William E. Janssen, PhD, the principal of WEJ Cell and Gene Therapy Consulting Services, will explain exactly what attendees need to know about comparability, including:
FDA requirements for comparability studies for gene and cell therapy products
Best practices for risk analysis and mitigation using comparability studies
How to design an effective comparability protocol for a gene or cell therapy product
How to construct a statistical approach to comparability
How to assemble the comparability package to comply with FDA requirements
An update on FDA regulatory announcements that include forming a consortium to deal with rare diseases and potential guidance about intermediate pathways
Webinar Details Gene & Cell Therapy Regulation: Comparability and Other New Developments An FDAnews Webinar Wednesday, December 14, 2022, 1:30 p.m.?3:00 p.m. EST https://wcg.swoogo.com/gene-t-cell-therapy-regulation
About FDAnews: WCG FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on WCG FDAnews' newsletters, books, databases, webinars and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations. Learn more at fdanews.com.
The Hong Kong Polytechnic University (PolyU) is partnering with ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments, to expand the global impact and speed up the market penetration of PolyU's...
Weibo Corporation (the "Weibo" or "Company") , a leading social media platform in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission on...
NETSCOUT SYSTEMS, INC. today released findings from its 2H2023 DDoS Threat Intelligence Report that dissects trends and attack methodologies adversaries use against service providers, enterprises, and end-users. The information cited in the report...
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Personalized Nutrition Market ? (By Purchase Model (Subscription, One Time Purchase), By End-users (Direct Consumers, Wellness & Fitness Centers,...
Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer's disease, macular degeneration, and glaucoma research grant funding?age-related diseases with no cure that affect more than 335 million people worldwide.
This year's...
Bigleaf Networks, a leading provider of wired and wireless network optimization solutions, today announced it has been presented with a Bronze Stevie Award of the technology industries category in the 18th annual Stevie Awards for Sales & Customer...